mata-uang-digital
no_dataFlash
21:22
Cardiff Oncology, Inc. (CRDF) has filed documents with the U.S. Securities and Exchange Commission (SEC), disclosing that it has initiated a lawsuit against Nerviano Medical Sciences, accusing the latter of breaching the licensing agreement regarding the investigational drug Onvansertib.According to the submitted SEC filing, Cardiff Oncology accuses Nerviano Medical Sciences of failing to fulfill its obligations under the license agreement, constituting a breach of contract. The core dispute in this lawsuit centers on the rights and responsibilities related to Onvansertib. This legal action marks a significant divergence between the two parties in their cooperation on the development of Onvansertib. Through this move, Cardiff Oncology seeks legal remedies to protect the rights it enjoys under the license agreement. The course of the incident may affect the future research, development, and commercialization of Onvansertib.
21:22
Bank First Corp has officially announced its share exchange plan, whose core content is as follows: each outstanding share of PSB common stock will be converted into the right to receive 0.3470 shares of BFC common stock.This share swap ratio clarifies the value conversion relationship between the two parties to the transaction, marking a key step in the integration process of both institutions. According to this plan, PSB shareholders will proportionally become BFC shareholders, and their shareholding structure will change accordingly.
21:11
On May 19, the MSCI Emerging Markets Currency Index fell by 0.3%, with the Brazilian Real and Korean Won performing the worst, both declining by around 1%.The MSCI Emerging Markets Index, as a peer index, plummeted by 1.45%, with the cumulative decline over the past three days expanding to more than 4.5%, marking the largest three-day consecutive drop since the end of March 2026. Leading decliners on Tuesday among heavyweights included Seoul-listed memory chip giant SK Hynix and TSMC.